Merck taps Cyprumed’s drug delivery platform for oral peptidesnews2025-04-15T07:00:03+00:00April 15th, 2025|Endpoints News|
Pfizer’s next move after ending work on oral obesity drug danuglipronnews2025-04-14T17:14:54+00:00April 14th, 2025|Endpoints News|
Tempest seeks strategic alternatives to fund Phase 3 liver cancer trialnews2025-04-10T11:15:45+00:00April 10th, 2025|Endpoints News|
Biotech market meltdown will leave some startups looking at survival playbooknews2025-04-09T15:00:42+00:00April 9th, 2025|Endpoints News|
PureTech rejects cash exit proposal from Nordic Capital after deal talksnews2025-04-07T19:39:12+00:00April 7th, 2025|Endpoints News|
GSK’s newest neuro pact is with ABL Bio, a Sanofi-partnered South Korean biotechnews2025-04-07T05:44:19+00:00April 7th, 2025|Endpoints News|
Eli Lilly pays struggling Sangamo $18M upfront to tap gene therapy capsidnews2025-04-04T10:53:40+00:00April 4th, 2025|Endpoints News|
F-star management takes company private, two years after $161M cash exit to Sino’s invoXnews2025-04-04T02:01:44+00:00April 4th, 2025|Endpoints News|
Tang Capital’s Concentra nabs a win, making a deal to buy Allakosnews2025-04-02T14:52:14+00:00April 2nd, 2025|Endpoints News|
New CDMO emerges, acquires cell and gene manufacturer Landmark Bionews2025-04-02T09:00:38+00:00April 2nd, 2025|Endpoints News|
